About

Dr. Drummond is a board-certified pulmonary and critical care physician. His clinical expertise includes chronic obstructive lung disease (COPD), alpha-1 antitrypsin deficiency, and smoking cessation. He is also a clinical and translational researcher whose research focus includes characterizing the mechanisms for development of chronic lung disease in individuals at-risk or with chronic obstructive pulmonary disease (COPD). He has expertise in epidemiology and clinical trials design, and has applied these skills to understand the pattern and risk factors for lung function progression in smokers as well as HIV-infected individuals. His primary projects include an NHLBI-funded study of the role of nasal mucosal immunity and microbiome on COPD disease control as well as participating with the Subpopulations and intermediate outcome measures in COPD study (SPIROMICS).

Additionally, Dr. Drummond is involved in characterizing the longitudinal impact of smoking, HIV infection and tobacco dependence on long-term outcomes related to chronic obstructive pulmonary disease. He is the director of the UNC Obstructive Lung Diseases Clinical and Translational Research Center, where he oversees clinical research studies supported by NIH and industry sponsors.

Listen to a podcast about COPD with Dr. Drummond. 

Learn more about Dr. Drummond’s work with the American Thoracic Society MECOR China Program.